In mice there was no detectable off-tumor and off-target infections, even though the potential of spread to tissues with low level expression of the targeted receptor (HER-2, in our case) remains to be verified in humans for any given retargeted oHSV. The gene discussed is ERBB2; the disease is neoplasm.